Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Marie

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Neuropharmacology|August 26, 2020
Impact of T161, Y318 and S363 alanine mutations on regulation of the human delta-opioid receptor (hDOPr) induced by peptidic and alkaloid agonistsElise Camacho, Nicolas Marie, Quentin Dupas, et al.
Toxicology Letters|January 9, 2013
Comparison of tolerance to morphine-induced respiratory and analgesic effects in miceWasseem Mohammed, Hisham Alhaddad, Nicolas Marie, et al.
Metabolism: Clinical and Experimental|March 24, 2009
Metformin suppresses high glucose-induced poly(adenosine diphosphate-ribose) polymerase overactivation in aortic endothelial cellsMeriem Mahrouf-Yorgov, Nicolas Marie, Didier Borderie, et al.
Toxicology and Applied Pharmacology|September 20, 2005
Buprenorphine is protective against the depressive effects of norbuprenorphine on ventilationBruno Mégarbane, Nicolas Marie, Stéphane Pirnay, et al.
Psychopharmacology|August 5, 2020
Chronic exposure to cocaine is associated with persistent behavioral disturbances. A cross-sectional dimensional study in outpatients with multiple substance use disordersFlorence Vorspan, Pauline de Witt, El-Hadi Zerdazi, et al.
Cellular Signalling|November 22, 2011
ßarrestin1-biased agonism at human δ-opioid receptor by peptidic and alkaloid ligandsBenjamin Aguila, Laurent Coulbault, Audrey Davis, et al.
Frontiers in Endocrinology|October 25, 2021
Effect of Monoclonal Antibody Blockade of Long Fragment Neurotensin on Weight Loss, Behavior, and Metabolic Traits After High-Fat Diet Induced ObesityZherui Wu, Nicolas Stadler, Amazigh Abbaci, et al.
The International Journal of Neuropsychopharmacology|June 21, 2023
Activation of the Mu-Delta Opioid Receptor Heteromers Blocks Morphine Rewarding EffectsAriadna Requana Aradas, Youssra Djaboub, Isabelle McCort-Tranchepain, et al.
British Journal of Pharmacology|August 28, 2020
TREK1 channel activation as a new analgesic strategy devoid of opioid adverse effectsJérôme Busserolles, Ismail Ben Soussia, Laetitia Pouchol, et al.
Journal for Immunotherapy of Cancer|June 11, 2025
Low-dose photodynamic therapy promotes vascular E-selectin expression in chest malignancies, improving immune infiltration and tumor controlLouis-Emmanuel Chriqui, Damien Nicolas Marie, Alexandros Sifis, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Neuropharmacology|August 26, 2020
Impact of T161, Y318 and S363 alanine mutations on regulation of the human delta-opioid receptor (hDOPr) induced by peptidic and alkaloid agonistsElise Camacho, Nicolas Marie, Quentin Dupas, et al.
Toxicology Letters|January 9, 2013
Comparison of tolerance to morphine-induced respiratory and analgesic effects in miceWasseem Mohammed, Hisham Alhaddad, Nicolas Marie, et al.
Metabolism: Clinical and Experimental|March 24, 2009
Metformin suppresses high glucose-induced poly(adenosine diphosphate-ribose) polymerase overactivation in aortic endothelial cellsMeriem Mahrouf-Yorgov, Nicolas Marie, Didier Borderie, et al.
Toxicology and Applied Pharmacology|September 20, 2005
Buprenorphine is protective against the depressive effects of norbuprenorphine on ventilationBruno Mégarbane, Nicolas Marie, Stéphane Pirnay, et al.
Psychopharmacology|August 5, 2020
Chronic exposure to cocaine is associated with persistent behavioral disturbances. A cross-sectional dimensional study in outpatients with multiple substance use disordersFlorence Vorspan, Pauline de Witt, El-Hadi Zerdazi, et al.
Cellular Signalling|November 22, 2011
ßarrestin1-biased agonism at human δ-opioid receptor by peptidic and alkaloid ligandsBenjamin Aguila, Laurent Coulbault, Audrey Davis, et al.
Frontiers in Endocrinology|October 25, 2021
Effect of Monoclonal Antibody Blockade of Long Fragment Neurotensin on Weight Loss, Behavior, and Metabolic Traits After High-Fat Diet Induced ObesityZherui Wu, Nicolas Stadler, Amazigh Abbaci, et al.
The International Journal of Neuropsychopharmacology|June 21, 2023
Activation of the Mu-Delta Opioid Receptor Heteromers Blocks Morphine Rewarding EffectsAriadna Requana Aradas, Youssra Djaboub, Isabelle McCort-Tranchepain, et al.
British Journal of Pharmacology|August 28, 2020
TREK1 channel activation as a new analgesic strategy devoid of opioid adverse effectsJérôme Busserolles, Ismail Ben Soussia, Laetitia Pouchol, et al.
Journal for Immunotherapy of Cancer|June 11, 2025
Low-dose photodynamic therapy promotes vascular E-selectin expression in chest malignancies, improving immune infiltration and tumor controlLouis-Emmanuel Chriqui, Damien Nicolas Marie, Alexandros Sifis, et al.
Pageof 4